Related Experiment Video

Updated: Jun 29, 2025

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.3K

RAS/Mitogen-Activated Protein Kinase Signaling Pathway in Testicular Germ Cell Tumors

Angelo Onorato1, Eugenia Guida1, Ambra Colopi1

  • 1Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Life (Basel, Switzerland)
|March 28, 2024
PubMed

Insights

Testicular germ cell tumors (TGCTs) involve key genes like KIT and K-RAS. Research explores the KIT-RAS pathway for potential precision medicine targets in these rare cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Germ cell tumors (GCTs) are the most common testicular cancers in young men (15-40 years).
  • TGCTs exhibit high aneuploidy and few somatic mutations, with KIT and K-RAS being significantly mutated genes.
  • Receptor Tyrosine Kinase (RTK) and Mitogen-Activated Protein Kinase (MAPK) pathways regulate crucial cellular functions and are implicated in various cancers.

Purpose of the Study:

  • To review the role of genetic and epigenetic factors in testicular germ cell tumor (TGCT) pathogenesis.
  • To examine the KIT-RAS pathway's involvement in TGCTs and other cancers.
  • To highlight potential targetable markers for precision medicine in TGCTs.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of genomic and transcriptomic data.
  • Focus on PGC survival, proliferation, differentiation, and TGCT pathogenesis.

Main Results:

  • Identified KIT and K-RAS as significantly mutated genes in TGCTs.
  • Highlighted the importance of the RTK/MAPK pathway in TGCT development.
  • Emphasized the potential for precision medicine approaches targeting this pathway.

Conclusions:

  • The KIT-RAS pathway is a critical area for understanding TGCT pathogenesis.
  • Targeting the KIT-RAS pathway offers promise for novel precision therapies in testicular cancer.
  • Further research into molecular markers is essential for advancing TGCT treatment.
Keywords:
KITMAPKPGCRAScancerepigeneticstesticular germ cell tumors (TGCTs)

More Related Videos

Germ Cell Transplantation and Testis Tissue Xenografting in Mice10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

29.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K